What Is a Medical Science Liaison (MSL)? A Guide for PhDs

You have a PhD and deep expertise. MSL roles turn that into a career path many PhDs never consider.

If you’re a PhD scientist and someone mentioned “MSL” in passing, you probably nodded and moved on. Medical Science Liaison sounds like a title designed to confuse. It is. But the role itself is worth understanding, especially if you want to stay in science but move away from the bench, travel less than field-based industry roles typically require, and build a career around scientific expertise and relationships.

This guide explains what MSLs actually do, who gets hired, what the compensation and lifestyle look like, and whether it’s a good fit for you.

What an MSL Actually Does (The Reality)

The job description says: “MSLs serve as the scientific bridge between pharmaceutical companies and healthcare providers, key opinion leaders, and academic medical centers.”

What does that mean in practice?

An MSL spends their time building and maintaining relationships with doctors, research scientists, and medical institutions who prescribe or use their company’s drugs or medical devices. They do this by:

Scientific education: You discuss clinical trial data, mechanism of action, pharmacokinetics, and safety data with physicians. This is not a sales pitch. It’s a technical conversation between people who understand the science.

Evidence gathering: You listen to what doctors see in their clinics, what questions they have, what concerns come up. You report this back to medical affairs and research teams. You’re the intelligence network.

Advisory boards and meetings: You organize and run meetings where physicians and researchers discuss your company’s products and pipeline. You facilitate scientific discussions. You take notes. You translate between what the physicians want and what the company needs to know.

Speaking and presentations: You present at medical conferences, run sponsored symposiums, teach CME courses about topics related to your company’s portfolio.

Publication strategy: You work with physicians and researchers to publish clinical insights and real-world evidence studies. You help identify publication opportunities.

Regulatory and compliance support: You stay current on FDA guidance, healthcare compliance, disclosure requirements. You ensure all interactions follow regulations.

Travel to see KOLs: You visit key opinion leaders, academic centers, and major hospital systems. You meet face-to-face with physicians to discuss science. This is where the travel comes in.

Travel typically runs 50-70% for field-based MSL roles. This is important. Some roles are more office-based (10-30% travel). Some are purely field-based and require serious commuting and hotel time. Ask about this explicitly in interviews.

The Day-to-Day Reality

Here’s what a typical week might look like:

Monday: Office time. Prep meeting materials for a physician advisory board happening Wednesday. Respond to requests from field reps asking about clinical data. Prepare for a call with a research hospital about their upcoming trial in your indication area.

Tuesday: Travel day. Drive to a major cancer center. Meet with two oncologists in the morning about recent trial data and their patient populations. Lunch with a hospital’s pharmacy director. Afternoon flight home.

Wednesday: Run the advisory board (6 physicians, 4 company staff). Facilitate discussion about unmet needs and where your company’s pipeline might fit. You’re taking notes and asking targeted questions. Not selling.

Thursday: Office time. Follow up with advisory board participants. Analyze feedback. Attend a medical education meeting. Review new clinical data your company received. Draft a summary for your team.

Friday: Hybrid. Morning in office preparing reports. Afternoon drive to another medical center for a one-on-one with a key researcher.

This is not repetitive sales work. It’s relationship management with a scientific foundation. Your expertise matters. The conversations are substantive. But it’s also not bench research. You’re no longer the person designing experiments.

MSL vs. Medical Affairs: What’s the Difference?

Medical Affairs is the broader function. MSLs are one part of it.

Medical Affairs departments include:

MSLs (field-based relationships)
Medical Information specialists (respond to healthcare provider inquiries about products)
Clinical Science specialists (work with clinical trials and study sites)
Pharmacovigilance specialists (monitor drug safety)
Medical directors and senior scientists (provide oversight and strategic direction)

As an MSL, you’re in the field. You build relationships. You’re the face of the company to key healthcare providers.

Other medical affairs roles are more office-based or focused on internal clinical or safety work. If you want scientific depth with less travel, those roles exist too.

Who Gets Hired as an MSL: Qualifications and Background

Most MSLs have advanced degrees:

PhD (biology, chemistry, biochemistry, pharmacology, or related field)
PharmD
MD

The PhD advantage: You have deep scientific expertise. You understand research. You can have credible conversations with academic researchers about mechanisms and data. Pharma companies value this, especially for early-stage medicines where the science is complex.

The PharmD advantage: You know pharmacology, drug development, and healthcare system basics that PhDs don’t. This is valuable if you want to move into roles faster without additional ramp-up.

The MD advantage: You know clinical practice. Physicians listen to you differently. This opens doors in some companies.

The field is increasingly flexible. Some companies hire MSLs with Master’s degrees if the candidate has deep domain expertise.

What matters more than the degree:

Ability to communicate complex science clearly
Comfort building relationships and networking
Interest in healthcare business, not just science
Geographic flexibility (you’ll need to move or accept extensive travel)
Tolerance for ambiguity in role definition
Sales aptitude (not always, but increasingly)

Salary and Total Compensation (2025-2026)

Entry-level MSL: $120,000-$160,000 total compensation (salary plus bonus) Mid-level MSL: $150,000-$200,000 Senior MSL / Regional MSL: $180,000-$240,000+

These are US figures, primarily East Coast and California biotech hubs. Salaries vary by:

Company size (large pharma typically pays more than biotech)
Therapeutic area (oncology and rare disease roles often pay more)
Geography (major biotech hubs command premiums)
Company performance (bonus varies widely)

Bonus structure typically ranges 15-30% of base salary, tied to individual and team performance metrics.

These are respectable numbers for non-leadership roles. For comparison, a postdoc makes $50,000-$60,000, and an Assistant Professor starting salary is often $100,000-$120,000. MSL comp is competitive with early-career academic positions, without the grant writing burden or publication pressure.

Source: MSLA (Medical Science Liaison Association) Compensation Survey, 2024-2025 (available to members; these figures align with industry reports).

How to Break In: Transition Paths from Academia

PhDs rarely go directly to MSL roles. There are intermediate steps.

Path 1: PhD -> Clinical/Medical Science Specialist -> MSL This is common. You take a medical affairs job focused on clinical operations, study site relationships, or medical information. You build healthcare knowledge and relationships. After 1-2 years, you transition to an MSL role. This path takes 2-3 years from PhD completion.

Path 2: PhD -> Postdoc -> MSL Less common but viable. You do a postdoc, especially if it’s at an academic hospital or involves clinical research. This adds credibility with clinical audiences. Then move to MSL. Timeline: 3-5 years.

Path 3: PhD -> Industry Research Scientist -> MSL You work in R&D or clinical development for a few years. You develop deep product knowledge and company relationships. Then transition to medical affairs. Timeline: 2-3 years.

What all these paths share: You’re building product knowledge and healthcare relationships. You’re not going directly from “I did a PhD in cancer genomics” to “I’m now an MSL in oncology” without interim steps.

Getting the first medical affairs job:

Network: Attend pharma-adjacent conferences. Connect with medical affairs leaders on LinkedIn. Attend MSLA meetups. Informational interviews are standard in this field.
Target companies with diversity programs: Large pharma companies (Roche, Novartis, Pfizer, BMS, Johnson & Johnson) run programs explicitly for PhD recruitment into medical affairs. Check career pages for “Early Career Programs” or “Graduate Programs.”
Consider biotech: Smaller biotech companies hire more flexibly. They may hire a PhD directly into medical science roles if you show interest and can demonstrate industry appetite.
Highlight healthcare exposure: If you have any clinical research, hospital affiliation, or healthcare system collaboration in your PhD, emphasize it.
Learn the language: Read recent FDA approvals in your disease area. Understand regulatory pathways. Follow industry news. In interviews, you need to show you understand the business side, not just the science.

What the Job Is Actually Like: The Honest Assessment

What you get:

Scientific depth. Your expertise is valued. You’re not a generalist. You go deep in your therapeutic area.
Autonomy. You manage your schedule, territory, and relationships. It’s not micromanaged.
Variety. No two days are identical. You’re meeting different people, discussing different topics, traveling to new places.
Intellectual engagement. You read literature, stay current, have technical conversations.
Decent work-life balance (in many roles). You’re not grinding 80-hour weeks like some R&D roles or clinical development roles.
Industry salary. You make respectable money without the grant-writing stress of academia.
Clear career path. Many MSLs move to director/manager roles, build to leadership.

What you give up:

Novelty of research. You’re not discovering something new. You’re explaining what’s already known.
Publication record. Your name doesn’t go on papers. This matters less in industry, but if you think you might go back to academia, it’s a gap.
Stability of the role. If your company’s drug gets rejected by the FDA or discontinued, your role might disappear. Pharma changes directions.
Predictable schedules. 50-70% travel means a lot of hotel time and disrupted personal life. Some people love this; many don’t.
Being the expert. Physicians are still the ultimate experts. You’re supporting them, not leading research. If you need to be the smartest person in the room, this job will frustrate you.
Pure scientific focus. You need to care about business metrics, market access, competitive landscape. If you only care about science and not market viability, this role will feel constraining.

The Ambiguity Question: Sales vs. Science

Here’s the tension: MSLs are often considered part of the “commercial” organization, not the “scientific” organization. This means you’re evaluated partly on commercial metrics: call effectiveness, account development, competitive positioning.

You’re not selling in the way a pharmaceutical sales rep does. You don’t have quota. You don’t use aggressive tactics. But you do need to be aware that your company benefits when physicians choose their drug. You need to be comfortable with that gray area.

If you think any focus on commercial impact is “selling out,” MSL roles will make you uncomfortable. If you’re comfortable explaining science while acknowledging that your employer has business interests, you’ll be fine.

This is different from academic science, where your job success is measured purely on research merit and publications.

The KOL Relationship Model

A lot of your time is building relationships with Key Opinion Leaders (KOLs): prominent physicians and researchers in your field.

This is normal and ethical. KOLs are paid (standardly, openly) for their time in advisory boards and speaking roles. This is legal and regulated. But it’s worth understanding: you’re partly evaluating them as potential speakers, advisors, and advocates for your company’s products. They know this. It’s transparent.

If the idea of compensating physicians for their time and perspective makes you uncomfortable, understand that this is standard healthcare practice and heavily regulated (Sunshine Laws, Physician Payments Sunshine Act). It’s not shadowy.

Common Challenges PhDs Face in MSL Roles

1. “I don’t feel like a scientist anymore.” Common. You read literature, you understand mechanisms, but you’re not running experiments. Some PhDs transition fine to this. Others find it unsatisfying. Think carefully about whether you actually care about doing research or whether you just care about science as a domain.

2. “Why am I explaining this to physicians who didn’t read the paper?” Frustration sets in when you realize not every doctor reads the latest data. MSL skills include patience and the ability to communicate at multiple levels. If you find that annoying, the role isn’t for you.

3. “The travel is brutal.” 50-70% travel sounds reasonable until you’re in a hotel 3 nights a week. Some people love it. Many burn out within 2-3 years. Ask yourself honestly how you handle travel.

4. “Company politics are intense.” Medical affairs sits between R&D, marketing, sales, and regulatory. You often have competing directives. Academia has politics too, but they’re different. Be prepared for this.

Bottom Line: Is MSL Right for You?

Consider an MSL role if:

You’re interested in science but don’t need to be running experiments
You enjoy talking to smart people about complex topics
You’re comfortable with business metrics and company strategy
You want geographic/lifestyle flexibility and can manage travel
You want a clear exit from academia without years of additional training
You’re interested in healthcare but not necessarily in clinical practice (PharmD/MD route)
You want to eventually move into business/leadership and need the credential

Skip MSL roles if:

You need to be conducting original research
Travel and relationship-building feel exhausting to you
You’re uncomfortable with any commercial focus
You want your name on publications
You need immediate impact and dislike the ambiguity of influence

Realistic Progression

If you start an MSL role in 2026:

Year 1-2: Ramp up. Learn the drug, the physicians in your territory, the company processes. You’re building relationships and credibility. Performance is measured partly on activity (calls, meetings) and partly on soft metrics (relationship strength, feedback quality).

Year 2-3: You become highly effective. You know your territory, the key KOLs, the common questions and concerns. You’re seeing the impact of your work.

Year 3-4: Career decision point. Some people want to stay deep in the MSL role. Others want to move: into management (managing other MSLs), into medical science roles, into commercial strategy, or back into R&D.

This timeline is realistic. You’re not an expert on day one, but you’re also not learning for 5+ years.

Next Steps

If you’re curious:

Connect with current MSLs. Find them on LinkedIn. Ask for 30-minute informational interviews. They’ll be honest about travel, politics, and what the role actually entails.
Understand the therapeutic area. Pick a disease or drug class you actually care about. MSL roles are more satisfying when you’re genuinely interested in the medical area.
Check job boards: Look at current MSL postings from large pharma and biotech companies. Read the job descriptions. See what the actual role requirements are.
Attend MSLA events (Medical Science Liaison Association). These are open to early-career professionals and give you a feel for the community.
Network within target companies. If you see a company’s drug that excites you, find their medical affairs people on LinkedIn and start conversations.

MSL roles are one of several paths for PhDs who want to stay in science without the bench. They’re not for everyone. But if you’re drawn to scientific conversations, relationship-building, and the healthcare industry, it’s a legitimate and lucrative path.

For the broader strategic picture of non-faculty scientific careers — including how to evaluate opportunities, build your reputation, and position yourself for advancement — A PhD Is Not Enough! by Peter Feibelman is required reading for any PhD considering industry.

Related: Navigating other PhD career paths? See our guide on PhD-to-biotech without a postdoc for a broader view of industry transitions, and our resource on LinkedIn for life scientists for networking strategies specific to the industry.